Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis

Antiviral Therapy

Volumn 10, Issue 3, 2005, Pages 417-422

  Michailidis, Christos ^a   Pozniak, Anton L ^a   Mandalia, Sundhiya ^a   Basnayake, Sheena ^a   Nelson, Mark R ^a   Gazzard, Brian G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFLAMMATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MIXED INFECTION; PRIORITY JOURNAL; SYNDROME; SYNDROME DELINEATION; TUBERCULOSIS; VIRUS LOAD; DRUG EFFECT; IMMUNITY; IMMUNOLOGY; MIDDLE AGED; TIME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY; INFLAMMATION; MALE; MIDDLE AGED; SYNDROME; TIME FACTORS; TUBERCULOSIS;

EID: 20444490353     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Campbell IA & Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 1977; 58:171-179.
2. Choremis CB, Padiatellis C, Zoumboulakis D & Yannakos D. Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children. American Review of Tuberculosis 1955; 72:527-536.
3. Chambers ST, Record C, Hendricks WA, Rudge WA & Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet 1984; 2:181-184.
4. Afghani B & Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clinical Infectious Diseases 1994; 19:1092-1099.
5. Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC & Johnson MA. Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clinical Infectious Diseases 1998; 26:1008-1009.
6. Furrer H & Malinverni R. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis. American Journal of Medicine 1999; 106:371-372.
7. John M & French MA. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Medical Journal of Australia 1998; 69:473-474.
8. Kunimoto DY, Chui L, Nobert E & Houston S. Immune mediated 'HAART' attack during treatment for tuberculosis: highly active antiretroviral therapy. International Journal of Tuberculosis & Lung Disease 1999; 3:944-947.
9. Mofredj A, Guerin JM, Leibinger F & Masmoudi R. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient [letter]. Infection 1996; 24:390-391.
10. Ramdas K & Minamoto GY. Paradoxical presentation of intracranial tuberculomas after chemotherapy in a patient with AIDS [letter]. Clinical Infectious Diseases 1994; 19:793-794.
11. Breen RA, Smith CJ, Bettinson H, Dart S, Bannister B, Johnson MA & Lipman MC. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 2004; 59:704-707.
12. Navas E, Martin-Davila P, Moreno E, Pintado V, Casado JL, Fortun J, Perez-Elias MJ, Gomez-Mampaso E & Moreno S. Paradoxical reactions of tuberculosis in patients with the aquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Archives of Internal Medicine 2002; 162:97-99.
13. Minguez C, Roca B, Gonzalez-Mino C & Simon E. Superior vena cava syndrome during the treatment of pulmonary tuberculosis in an HIV-1 infected patient. Journal of Infection 2000; 40:187-189.
14. Furrer H & Malinverni R. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis. American Journal of Medicine 1999; 106:371-372.
15. Fishman JE, Saraf-Lavi E, Narita M, Hollender ES, Ramsinghani R & Ashkin D. Transient chest radiographic worsening after initiation of antiretroviral therapy. American Journal of Roentgenology 2000; 174:43-49.
16. Hollender E, Narita M, Ashkin D, Nunez A, Akinlabi O, Huang N, Stambaugh JJ & McFeely J. CNS manifestations of paradoxical reactions in HIV+TB patients on HAART. 7th Conference on Retroviruses & Opportunistic Infections. 30 January-2 February 2000, San Francisco, CA, USA. Abstract 258.
17. Narita M, Ashkin D, Hollender ES & Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. American Journal of Respiratory & Critical Care Medicine 1998; 158:157-161.
18. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR & Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001; 120:193-197.
19. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A & Pozniak AL. Treatment of tuberculosis in HIV-1 infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16:75-83.
20. Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, Longuet P, Leport C & Vilde JL. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clinical Infectious Diseases 2004; 39:1709-1712.
21. Moreno S. [Tuberculosis in developing countries.] 14th International AIDS Conference. 7-12 July 2002, Barcelona, Spain. Abstract TUOR171.
22. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F & Reiss P. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 1999; 13:177-184.
23. Schluger NW, Perez D & Liu YM. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 2002; 122:597-602.
24. Judson MA. Highly active antiretroviral therapy for HIV with tuberculosis: pardon the granuloma. Chest 2002; 122:399-400.
25. Perez D, Liu Y, Jung T & Schluger NW. Reconstitution of host immunity to M tuberculosis in HIV-infected individuals [abstract]. American Journal of Respiratory & Critical Care Medicine 2000; 161:A224.
26. Price P, Mathiot N, Krueger R, Stere S, Keane NB & French MA. Immune restoration disease in HIV patients given highly active antiretroviral therapy. Journal of Clinical Virology 2001; 22:279-287.
27. Price P, Morahan G, Huang D, Stone E, Cheong KY, Castley A, Rodgers M, McIntyre MQ, Abraham LJ & French MA. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restortion diseases. AIDS 2002; 16:2043-2047.